EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Less is more: A single-dose, non-waiting neoadjuvant immunotherapy strategy for hepatocellular carcinoma

Kevin Kuan-Yu Chen, Tzu-Jung Lin, Te-Wei Su, Po-Da Chen, Ming-Chih Ho, Yao-Ming Wu, Ying-Chun Shen, Ann-Lii Cheng

Biomedical Journal · 2026-08 · 49 (4) · 100994

DOI: 10.1016/j.bj.2026.100994 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomedical Journal, 2026-08. Verfasst von Kevin Kuan-Yu Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Neoadjuvant Therapy, Immunotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsNeoadjuvant TherapyImmunotherapyImmune Checkpoint InhibitorsHumans

Stichwörter der Autor:innen

Hepatocellular carcinoma (HCC)Immune checkpoint inhibitor (ICI)Neoadjuvant immunotherapy

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan; Department of Surgery, National Taiwan University Cancer Center, Taipei, Taiwan.
  • Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan; Department of Surgery, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
  • Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan; Graduate Institute of Oncology, College of Medicine,…

Förderung

  • National Science and Technology Council

Zitieren

APA

Chen, K. K., Lin, T. J., Su, T. W., Chen, P. D., Ho, M. C., Wu, Y. M., Shen, Y. C., & Cheng, A. L. (2026). Less is more: A single-dose, non-waiting neoadjuvant immunotherapy strategy for hepatocellular carcinoma. Biomedical Journal, 49(4), 100994. https://doi.org/10.1016/j.bj.2026.100994

Vancouver

Chen KK, Lin TJ, Su TW, Chen PD, Ho MC, Wu YM, et al. Less is more: A single-dose, non-waiting neoadjuvant immunotherapy strategy for hepatocellular carcinoma. Biomedical Journal. 2026;49(4):100994. doi:10.1016/j.bj.2026.100994

BibTeX
@article{Chen2026,
  author = {Chen, Kevin Kuan-Yu and Lin, Tzu-Jung and Su, Te-Wei and Chen, Po-Da and Ho, Ming-Chih and Wu, Yao-Ming and Shen, Ying-Chun and Cheng, Ann-Lii},
  title = {Less is more: A single-dose, non-waiting neoadjuvant immunotherapy strategy for hepatocellular carcinoma},
  journal = {Biomedical Journal},
  year = {2026},
  volume = {49},
  number = {4},
  pages = {100994},
  doi = {10.1016/j.bj.2026.100994}
}
Kostenlos starten →